Dexamethasone produces dose-dependent inhibition of sugammadex reversal in in vitro innervated primary human muscle cells

Anesthesia and Analgesia

Volumn 118, Issue 4, 2014, Pages 755-763

  Rezonja, Katja ^a   Sostaric, Maja ^a   Vidmar, Gaj ^b   Mars, Tomaz ^c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b Institute for Biostatistics and Medical Informatics   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ROCURONIUM; SUGAMMADEX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG INHIBITION; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MUSCLE CONTRACTION; MUSCLE INNERVATION; NEURITIS; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANDROSTANOLS; ANESTHETICS, LOCAL; ANIMALS; ANTIEMETICS; COCULTURE TECHNIQUES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MICROSCOPY, PHASE-CONTRAST; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; PRIMARY CELL CULTURE; RATS; SPINAL CORD;

EID: 84897016740     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000108     Document Type: Article

References (39)

1. Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, Tijssen JG, Numan SC, Kalkman CJ, van Dijk D; Dexamethasone for Cardiac Surgery (DECS) Study Group. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA 2012;308: 1761-7
2. Shaikh S, Verma H, Yadav N, Jauhari M, Bullangowda J. Applications of steroid in clinical practice: a review. ISRN Anesthesiology 2012;Article ID 985495
3. De Oliveira GS Jr, Almeida MD, Benzon HT, McCarthy RJ. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology 2011;115: 575-88
4. Hval K, Kjetil H, Thagaard KS, Sem TK, Schlichting E, Ellen S, Raeder J, Johan R. The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (rofecoxib) before breast surgery. Anesth Analg 2007;105: 481-6
5. Henzi I, Walder B, Tramèr MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000;90: 186-94
6. De Oliveira GS Jr, Castro-Alves LJ, Ahmad S, Kendall MC, McCarthy RJ. Dexamethasone to prevent postoperative nausea and vomiting: an updated meta-analysis of randomized controlled trials. Anesth Analg 2013;116: 58-74
7. Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramèr MR, Watcha M and Department of Anesthesiology, Duke University Medical Center. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97: 62-71
8. Zhang M-Q. Drug-specific cyclodextrins: the future of rapid neuromuscular block reversal. Drugs Fut 2003;28: 347
9. Zwiers A, van den Heuvel M, Smeets J, Rutherford S. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic- pharmacodynamic modelling approach. Clin Drug Investig 2011;31: 101-11
10. Organon, Schering-Plough. FDA Anesthetic and Life Support Advisory Committee Meeting. Sugammadex Sodium Injection (NDA 22-225). March 11, 2008. Briefing Document (Background Package). Kenilworth, NJ: Organon, Schering- Plough Corporation, 2008
11. Rezonja K, Lorenzon P, Mars T. Opposing effects of dexamethasone, agrin and sugammadex on functional innervation and constitutive secretion of IL-6 in in vitro innervated primary human muscle cells. Neurosci Lett 2013;549: 186-90
12. Askanas V, Kwan H, Alvarez RB, Engel WK, Kobayashi T, Martinuzzi A, Hawkins EF. De novo neuromuscular junction formation on human muscle fibres cultured in monolayer and innervated by foetal rat spinal cord: ultrastructural and ultrastructural- cytochemical studies. J Neurocytol 1987;16: 523-37
13. Grubic Z, Komel R, Walker WF, Miranda AF. Myoblast fusion and innervation with rat motor nerve alter distribution of acetylcholinesterase and its mRNA in cultures of human muscle. Neuron 1995;14: 317-27
14. Mars T, Yu KJ, Tang XM, Miranda AF, Grubic Z, Cambi F, King MP. Differentiation of glial cells and motor neurons during the formation of neuromuscular junctions in cocultures of rat spinal cord explant and human muscle. J Comp Neurol 2001;438: 239-51
15. Mars T, King MP, Miranda AF, Walker WF, Mis K, Grubic Z. Functional innervation of cultured human skeletal muscle proceeds by two modes with regard to agrin effects. Neuroscience 2003;118: 87-97
16. Bandi E, Jevsek M, Mars T, Jurdana M, Formaggio E, Sciancalepore M, Fumagalli G, Grubic Z, Ruzzier F, Lorenzon P. Neural agrin controls maturation of the excitation-contraction coupling mechanism in human myotubes developing in vitro. Am J Physiol Cell Physiol 2008;294:C66-73
17. de Barcelos CC, Braga Ade F, Braga FS, Potério GB, Fernandes SC, Franco YO, Simioni LR. In vitro and in vivo neuromuscular effects of atracurium and rocuronium in rats treated with carbamazepine for seven days. Rev Bras Anestesiol 2008;58: 137-51
18. Gaafary MMH, Alkami EFA. Rocuronium bromide: a pharmacological study. Egypt J Hosp Med 2001;2: 1-10
19. Miller S, Bom AH. Org 25969 causes selective reversal of neuromuscular blockade induced by steroidal NMBs in the mouse hemi-diaphragm preparation: Eur J Anaesthesiol 2001;18: 100-1
20. Booij LH. Cyclodextrins and the emergence of sugammadex. Anaesthesia 2009;64 Suppl 1: 31-7
21. Bom AH, Thomson K. Effect of high doses of sugammadex on mouse hemi-diaphragm contractions during TOF stimulation. Anesthesiology 2006;105:A110
22. Bülbring E. Observations on the isolated phrenic nerve diaphragm preparation of the rat. Br J Pharmacol Chemother 1946;1: 38-61
23. van Miert MM, Eastwood NB, Boyd AH, Parker CJ, Hunter JM. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol 1997;44: 139-44
24. Szenohradszky J, Fisher DM, Segredo V, Caldwell JE, Bragg P, Sharma ML, Gruenke LD, Miller RD. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 1992;77: 899-904
25. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106: 935-43
26. Matteo RS, Ornstein E, Schwartz AE, Ostapkovich N, Stone JG. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg 1993;77: 1193-7
27. Staals LM, Snoeck MM, Driessen JJ, van Hamersvelt HW, Flockton EA, van den Heuvel MW, Hunter JM. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010;104: 31-9
28. Fernández-Candil J, Gambús PL, Trocóniz IF, Valero R, Carrero E, Fábregas N. Feasibility of microdialysis to determine interstitial rocuronium concentration in the muscle tissue of anesthetized neurosurgical patients. J Neurosurg Anesthesiol 2010;22: 163-9
29. Ezzine S, Varin F. Interstitial muscle concentrations of rocuronium under steady-state conditions in anaesthetized dogs: actual versus predicted values. Br J Anaesth 2005;94: 49-56
30. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004;350: 1629-38
31. Brady ME, Sartiano GP, Rosenblum SL, Zaglama NE, Bauguess CT. The pharmacokinetics of single high doses of dexamethasone in cancer patients. Eur J Clin Pharmacol 1987;32: 593-6
32. El Azab SR, Rosseel PM, de Lange JJ, Groeneveld AB, van Strik R, van Wijk EM, Scheffer GJ. Dexamethasone decreases the proto anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 2002;88: 496-501
33. Loef BG, Henning RH, Epema AH, Rietman GW, van Oeveren W, Navis GJ, Ebels T. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2004;93: 793-8
34. Morariu AM, Loef BG, Aarts LP, Rietman GW, Rakhorst G, van Oeveren W, Epema AH. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005;128: 2677-87
35. Yared JP, Bakri MH, Erzurum SC, Moravec CS, Laskowski DM, Van Wagoner DR, Mascha E, Thornton J. Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial. J Cardiothorac Vasc Anesth 2007;21: 68-75
36. Nigrovic V, Bhatt SB, Amann A. First human exposure to Org 25969. Anesthesiology 2006;105: 427; author reply 427
37. Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth 2009;103: 115-29
38. Manabe Y, Miyatake S, Takagi M, Nakamura M, Okeda A, Nakano T, Hirshman MF, Goodyear LJ, Fujii NL. Characterization of an acute muscle contraction model using cultured C2C12 myotubes. PLoS One 2012;7:e52592
39. Nikolić N, Bakke SS, Kase ET, Rudberg I, Flo Halle I, Rustan AC, Thoresen GH, Aas V. Electrical pulse stimulation of cultured human skeletal muscle cells as an in vitro model of exercise. PLoS One 2012;7:e33203